How safe are GLP-1 drugs, really?

GLP-1 medications have exploded in popularity over the past few years, and it’s easy to see why. They work. People lose significant weight, blood sugar improves, and for the first time in a long time, weight management feels achievable. But anytime a drug goes from niche diabetes treatment to cultural phenomenon in the span of a couple years, it’s worth stepping back and asking: how safe are these, really?

The short answer is that GLP-1s have a strong safety track record based on what we know so far. But “so far” is doing some heavy lifting in that sentence.

GLP-1 drugs aren’t brand new. Earlier versions like Victoza and Byetta have been used for type 2 diabetes since the mid-2000s. The newer, longer-acting versions like Ozempic and Wegovy were approved more recently (Ozempic in 2017, Wegovy in 2021), but they’ve been studied in large clinical trials involving thousands of patients over several years.

Those trials showed that the most common side effects are gastrointestinal: nausea, vomiting, diarrhea, constipation. Most of these are mild to moderate and improve over time. Serious adverse events were relatively rare, but they did happen. Pancreatitis showed up in a small number of patients, and gallbladder issues, including gallstones, were more common in people losing weight rapidly. There were also cases of worsening diabetic retinopathy in people with existing eye disease.

The trials also looked at cardiovascular outcomes, and the results were actually encouraging. GLP-1s reduced the risk of heart attack and stroke in people with diabetes and existing heart disease. That’s a big deal, because cardiovascular disease is one of the leading causes of death in people with obesity and diabetes.

The big caveat is that these trials followed people for a few years at most. We don’t have decades of data on what happens when someone takes a GLP-1 for ten or twenty years. We don’t know if there are long-term effects on the pancreas, thyroid, or other organs that only show up after prolonged use.

There’s also a thyroid cancer concern that comes up. In animal studies, GLP-1s caused thyroid tumors in rodents. This hasn’t been seen in humans so far, but it’s why these medications come with a warning about medullary thyroid carcinoma and why people with a personal or family history of this rare cancer shouldn’t take them.

Another unknown is what happens when large numbers of people use these drugs in the real world, outside the controlled environment of a clinical trial. We’re already seeing reports of complications that weren’t as obvious in trials, like severe gastroparesis (stomach paralysis), or aspiration during anesthesia because food stays in the stomach longer than expected.

The FDA and drug manufacturers are actively monitoring for these issues, but real-world data takes time to accumulate. This is normal for any medication, but it’s worth being aware of.

Certain people are not good candidates for these medications. If you’re pregnant or trying to get pregnant, GLP-1s are off the table. Animal studies showed potential harm to developing fetuses, and there’s not enough human data to know if they’re safe during pregnancy. If you’re on a GLP-1 and want to get pregnant, you’ll need to stop the medication at least two months before trying to conceive.

Breastfeeding is also a no-go. We don’t know if GLP-1s pass into breast milk or what effect they might have on a nursing infant, so the recommendation is to avoid them while breastfeeding.

If you have a history of pancreatitis, medullary thyroid cancer, or multiple endocrine neoplasia syndrome type 2 (a genetic condition), GLP-1s aren’t for you. If you have severe gastroparesis or digestion issues, these drugs could make things worse.

Additionally, people with a history of eating disorders should approach GLP-1s cautiously. The appetite suppression can be intense, and for someone with a complicated relationship with food, that can be problematic.

GLP-1 drugs are generally safe for most people when used as prescribed and monitored by a doctor. The benefits (significant weight loss, better blood sugar control, reduced cardiovascular risk) are real and well-documented. But they’re not risk-free, and we’re still learning about long-term effects.

If you’re considering a GLP-1, the key is going in with your eyes open. Talk to your doctor about your medical history, understand the known risks, and recognize that we’re still in relatively early days for some of these medications. That doesn’t mean they’re unsafe – it just means that like any medical decision, it’s about weighing what we know against what we don’t, and deciding what makes sense for you.